Skip to main content
Fig. 1 | Genome Medicine

Fig. 1

From: Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making

Fig. 1

Comparison of genes on commercial laboratory NBS panels. Venn diagram summarizing all of the overlapping or distinct genes from BabyGenes Supplemental Newborn Screening, Sema4 Natalis, Fulgent Newborn Genetic Analysis NGS Panel, and PerkinElmer Expanded Newborn Screening and Gene Sequencing Panel using a free Ghent University Bioinformatics and Evolutionary Genomics software tool [23]. A single gene entry for HBA1/HBA2 on Sema4 Natalis was split for comparison, and the total number of genes on the panel changed from 166 to 167

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us